Eculizumab Biosimilar ABP 959 Demonstrates Similarity to Reference in Patients With PNH AJMC, 06 Dec 2023 The efficacy and pharmacokinetics of ABP 959, an eculizumab biosimilar from Amgen, and its reference product (Soliris) were…